Detection of left ventricular regional dysfunction and myocardial abnormalities using complementary cardiac magnetic resonance imaging in patients with systemic sclerosis without cardiac symptoms: A pilot study

Internal Medicine

Volumn 55, Issue 3, 2016, Pages 237-243

  Kobayashi, Yasuyuki ^a   Kobayashi, Hitomi ^b   Giles, Jon T ^c   Yokoe, Isamu ^d   Hirano, Masaharu ^e   Nakajima, Yasuo ^a   Takei, Masami ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c College of Physicians and Surgeons ^*  (United States)

^d Division of Rheumatology   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac magnetic resonance imaging; LV regional dysfunction; Myocardial abnormalities; Systemic sclerosis

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FINGER ULCER; HEART LEFT VENTRICLE FAILURE; HUMAN; LATE GADOLINIUM ENHANCEMENT; MALE; MEDICAL SOCIETY; MIDDLE AGED; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE SCANNER; PEAK REGIONAL CIRCUMFERENTIAL STRAIN; PEAK REGIONAL RADIAL STRAIN; PILOT STUDY; SYSTEMIC SCLEROSIS; CARDIAC MUSCLE; COMPARATIVE STUDY; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SCLERODERMA, SYSTEMIC; SYSTOLE;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PILOT PROJECTS; SCLERODERMA, SYSTEMIC; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84956650099     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.55.4441     Document Type: Article

References (17)

1. Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis:demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81: 139-153, 2002.
2. Buss SJ, Breuninger K, Lehrke S, et al. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 16: 307-315, 2015.
3. Glaveckaite S, Valeviciene N, Palionis D, et al. Prediction of longterm segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 16: 83, 2014.
4. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590, 1980.
5. Castillo E, Lima AC, Bluemke DA. Regional myocardial function: advances in MR imaging and analysis. Radiographics 23: S127-S140, 2003.
6. Hor KN, Baumann R, Pedrizzetti G, et al. Magnetic resonance derived myocardial strain assessment using feature tracking. J Vis Exp 48: 2356-2361, 2011.
7. Maret E, Todt T, Brudin L, et al. Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar. Cardiovasc Ultrasound 7: 53, 2009.
8. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 34: 775-781, 2013.
9. Kim RJ. Assessment of myocardial viability by contrast enhancement. In: MRI and CT of the Cardiovascular System. 2nd ed. Higgins CB, Roos A, Eds. Lippincott Willams & Wilkins, Philadelphia, 2006: 233-262.
10. D’Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls. Am J Med 46: 428-440, 1965.
11. Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis: A cause of cardiac dysfunction. Circulation 53: 483-490, 1976.
12. Botstein GR, LeRoy EC. Primary heart disease in systemic sclerosis (scleroderma): advances in clinical and pathologic features, pathogenesis, and new therapeutic approaches. Am Heart J 102: 913-919, 1981.
13. Kobayashi H, Yokoe I, Hirano M, et al. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatology 36: 106-112, 2009.
14. Altiok E, Tiemann S, Becker M, et al. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance. J Am Soc Echocardiogr 27: 249-257, 2014.
15. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109: 1250-1258, 2004.
16. Hoffmann R, Altiok E, Friedman Z, et al. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis. Am J Cardiol 114: 1083-1088, 2014.
17. Miszalski-Jamka T, Szczeklik W, Soko_owska B, et al. Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener’s) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging 29: 843-853, 2013.